Skip to main content
. 2014 Nov 16;2014:202983. doi: 10.1155/2014/202983

Table 2.

Predictors of unsuccessful tuberculosis treatment outcomes among 233 rural TB/HIV patients in Ebonyi State, Nigeria, 2011-2012.

Characteristics Successful outcome
n (%)
Unsuccessful outcome
n (%)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Adjusted P value
Age (years)
 ≤40 106 (60.6) 69 (39.4) 1.07 (0.6–2.0) 1.06 (0.5–2.1) 0.86
 >40 36 (62.1) 22 (37.9) 1 1
Gender
 Female 65 (58.0) 47 (42.0) 1.26 (0.8–2.1) 1.26 (0.7–2.3) 0.43
 Male 77 (63.6) 44 (36.8) 1 1
Facility
 Public 23 (38.3) 37 (61.7) 3.6 (1.9–6.5) 3.8 (1.9–7.7) <0.001
 Private 119 (68.8) 54 (31.2) 1 1
Treatment category
 New 132 (60.8) 85 (39.2) 1.07 (0.4–3.1) 1.06 (0.4–3.2) 0.92
 Previously treated 10 (62.5) 6 (37.5) 1 1
Type of TB
 Pulmonary 139 (61.8) 86 (38.2) 1 1
 Extrapulmonary 3 (37.5) 5 (62.5) 2.7 (0.6–11.6) 1.2 (0.3–6.0) 0.80
Anti-TB regimen
 Regimen 1 72 (55.8) 57 (44.2) 1.6 (0.9–2.8) 1.7 (0.9–3.2) 0.096
 Regimen 2 70 (67.3) 34 (32.7) 1 1
Received ART
 Yes 47 (58.8) 33 (41.2) 1.2 (0.7–2.0) 1.2 (0.5–2.5) 0.71
 No 95 (62.1) 58 (37.9) 1 1
Received CPT
 Yes 79 (60.3) 52 (39.7) 1.06 (0.6–1.8) 1.0 (0.5–2.0) 0.98
 No 63 (61.8) 39 (38.2) 1 1

Regimen 1: 2RHZE/6EH; regimen 2: 2RHZE/4RH (R: rifampicin, H: isoniazid, Z: pyrazinamide, and E: ethambutol); OR: odds ratio; ART: antiretroviral therapy; TB: tuberculosis; HIV: human immunodeficiency virus; CPT: cotrimoxazole preventive therapy.